Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds BTIG Upgrades Agilysys to Buy

BTIG Upgrades Agilysys to Buy

BTIG analyst Matthew Vanvliet upgrades Agilysys (NASDAQ:AGYS) from Neutral to Buy.

byBenzinga Newsdesk

December 16, 2022

1 minute read

BTIG analyst Matthew Vanvliet upgrades Agilysys (NASDAQ:AGYS) from Neutral to Buy.

Analyst Ratings

What 11 Analyst Ratings Have To Say About Avadel Pharmaceuticals

By Benzinga Insights

May 30, 4:01 PM

Analysts have provided the following ratings for Avadel Pharmaceuticals (NASDAQ:AVDL) within the last quarter: Bullish Somewhat Bullish Indifferent…

AVDL

Bank of America To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Tuesday

By Avi Kapoor

January 2, 8:22 AM

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

AAPL

Piper Sandler Maintains Overweight on ConocoPhillips, Lowers Price Target to $123

By Benzinga Newsdesk

July 19, 7:08 AM

Piper Sandler analyst Ryan Todd maintains ConocoPhillips (NYSE:COP) with a Overweight and lowers the price target from $148 to $123.

COP

These 2 Auto Insurers Are Refusing To Cover Certain Models Made By Kia And Hyundai: Here’s Why

By Bibhu Pattnaik

February 5, 12:24 PM

Two of America's largest car insurers, State Farm and Progressive Corp (NYSE: PGR), are refusing to cover select models of a pair of South Korean automakers</

HYMTF

BTIG Upgrades Agilysys to Buy

Related Posts

What 11 Analyst Ratings Have To Say About Avadel Pharmaceuticals

Bank of America To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Tuesday

Piper Sandler Maintains Overweight on ConocoPhillips, Lowers Price Target to $123

These 2 Auto Insurers Are Refusing To Cover Certain Models Made By Kia And Hyundai: Here’s Why